Dear Members,<\/p>\n
Further to the CEO Meeting announcing the RSA pilot between the industry and HA, we are pleased to invite you to join a follow-up workshop to support members\u2019 preparation for potential RSA\/MEA pilot submissions.<\/p>\n
Workshop:<\/strong> Preparing for RSA Pilots with the Hospital Authority: From International Experience to Practical Proposals We are delighted to have Dr. Indranil Bagchi<\/strong> join us to share international experience on risk-sharing arrangements and managed-entry agreements. Dr. Bagchi will discuss how RSAs and MEAs can help manage uncertainty in efficacy, cost-effectiveness, budget impact, and long-term outcomes, and share relevant international examples and lessons for Hong Kong.<\/p>\n The workshop will also include a co-creation session to develop a draft template for submission to CPO, covering proposed RSA\/MEA models, supporting evidence, data requirements, implementation considerations, and measures of success. Members will have the opportunity to exchange views and contribute to practical next steps for the RSA pilot.<\/p>\n The workshop will be particularly relevant to colleagues involved in HA engagement, drug listing, evidence generation, pricing, and pilot preparation.<\/p>\n During registration, please kindly provide your job title<\/strong>. This information will help us organize the group discussions in Session 2 and ensure a balanced mix of perspectives.<\/p>\n Please register by contacting Ms Catherine Chau of the HKAPI Office.<\/p>\n","protected":false},"excerpt":{"rendered":" Dear Members, Further to the CEO Meeting announcing the RSA pilot between the industry and HA, we are pleased to invite you to join a follow-up workshop to support members\u2019 […]<\/p>\n","protected":false},"author":91,"featured_media":21849,"template":"","meta":{"rs_blank_template":"","rs_page_bg_color":"","slide_template_v7":"","_tribe_events_status":"","_tribe_events_status_reason":"","footnotes":""},"tags":[90,152,86],"tribe_events_cat":[151,67],"class_list":["post-21848","tribe_events","type-tribe_events","status-publish","has-post-thumbnail","hentry","tag-market-access","tag-rsa","tag-workshop","tribe_events_cat-market-access","tribe_events_cat-members-only","cat_market-access","cat_members-only"],"_links":{"self":[{"href":"https:\/\/hkapi.hk\/zh\/wp-json\/wp\/v2\/tribe_events\/21848","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hkapi.hk\/zh\/wp-json\/wp\/v2\/tribe_events"}],"about":[{"href":"https:\/\/hkapi.hk\/zh\/wp-json\/wp\/v2\/types\/tribe_events"}],"author":[{"embeddable":true,"href":"https:\/\/hkapi.hk\/zh\/wp-json\/wp\/v2\/users\/91"}],"version-history":[{"count":2,"href":"https:\/\/hkapi.hk\/zh\/wp-json\/wp\/v2\/tribe_events\/21848\/revisions"}],"predecessor-version":[{"id":21852,"href":"https:\/\/hkapi.hk\/zh\/wp-json\/wp\/v2\/tribe_events\/21848\/revisions\/21852"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/hkapi.hk\/zh\/wp-json\/wp\/v2\/media\/21849"}],"wp:attachment":[{"href":"https:\/\/hkapi.hk\/zh\/wp-json\/wp\/v2\/media?parent=21848"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hkapi.hk\/zh\/wp-json\/wp\/v2\/tags?post=21848"},{"taxonomy":"tribe_events_cat","embeddable":true,"href":"https:\/\/hkapi.hk\/zh\/wp-json\/wp\/v2\/tribe_events_cat?post=21848"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nDate & Time:<\/strong> 20 November 2026, 2:30 pm \u2013 5:00 pm
\nFormat: <\/strong>Face-to-Face only
\nVenue:<\/strong> Please contact the HKAPI Office for details
\nSpeaker:<\/strong> Dr. Indranil Bagchi, Global Head of Pricing & Market Access, GSK<\/p>\n